Governance & administration

LIH governance includes the Executive Committee and the Board of Directors. 

Board of directors

The Board of Directors oversees the work of the Luxembourg Institute of Health. It is responsible for the general organisation, for budget control, for framework contracts with partner organisations and for approving new strategy. 

The Government nominated the new Board of Directors, which took office on January 1st 2025, as follows: 

  • Ana
    Sanchez-Guevara     Associate Medical Director,
    Robert Schuman Hospitals (Luxembourg),
    President of the Board of Directors
  • Xavier
    Poos     Deputy Administrative Director,
    Health Directorate of the Ministry of Health (Luxembourg),
    Vice-President of the Board of Directors
  • Lysiane
    Back     Retired, former Vice-President, BCEE (Luxembourg)
  • Rudi
    Balling     Group Leader Molecular Psychiatry,
    Institute of Molecular Psychiatry,
    University of Bonn (Germany)
  • Françoise
    Berthet     President of the Observatoire National de la Santé (Luxembourg)
  • Alexandre
    Bisdorff     Neurologist (Luxembourg)
  • Carole
    Brueckler     Head of Digital Health Technologies,
    Ministry of the Economy Directorate General Industry,
    New Technologies and Research (Luxembourg)
  • Alain
    Kohl     Chair in Virology and Emerging Infectious Diseases,
    Liverpool School of Tropical Medicine (United Kingdom)
  • Céline
    Marchand     Attorney at Law, Hansen Mueller Marchand (Luxembourg)
  • Jérôme
    Paggetti     Group Leader Department of Cancer Research,
    Luxembourg Institute of Health,
    President of the Conseil de Concertation (Luxembourg)
  • Olivier
    Keunen     Group Leader Department of Cancer Research,
    Luxembourg Institute of Health,
    President of the Delegation de Personnel (Luxembourg)
Pierre
Misteri

In addition, Pierre Misteri, Advisor at the Ministry of Higher Education and Research, is Government Commissioner (“Commissaire du Gouvernement”). 

executive committee

The Executive Committee is responsible for the implementation of the strategy approved by the board of administration. It guarantees compliance with ethical principles, conventions and national laws. 

The Executive Committee is composed of: 

  • Ulf
    Nehrbass     Chief Executive Officer
  • Frank
    Glod     Deputy Chief Executive Officer
  • Stefan
    Debast     Chief Financial & Administrative Officer
  • Guy
    Fagherazzi     PhD
    Research Group Leader
    Director of Department of Precision Health
  • Johannes
    Meiser     PhD
    Research Group Leader
    Director of Department of Cancer Research
  • Markus
    Ollert     Professor, MD
    Research Group Leader
    Director of Department of Infection and Immunity
  • Hermann
    Thien     PhD
    Director of Translational Medicine Operations Hub
  • Maximilian
    Fünfgeld     PhD
    Director of Department of Medical Informatics

Scientific Advisory Boards 

The Scientific Advisory Boards (SAB) are consultative bodies to the Board of Administration and are composed of high-ranking external scientists.  The SABs’ composition reflects the scientific areas in which the Luxembourg Institute of Health is active. 

Administration

From business development support – and specifically the exploitation of the scientific, economic and societal value and applications of research results − to scientific project management support and assistance in securing external funding opportunities: a rigorous quality management system, legal and data protection framework is in place in order to ensure that research activities are carried out in full compliance with current best practices and regulatory requirement, thereby guaranteeing the quality, transparency and rigour of the institute’s operations.